FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology. Described is a group of inventions comprising a compound for inhibiting complement factor B (CFB) expression (embodiments), a pharmaceutical composition for treating a disease associated with deregulation of an alternative complement pathway in a subject, a method of treating a disease associated with deregulation of an alternative complement pathway in a subject, use of said compound or composition for treating a disease associated with dysregulation of an alternative complement path, using said compound or composition when preparing a drug for treating a disease associated with deregulation of an alternative complement pathway. In one embodiment, the compound contains a modified oligonucleotide and a conjugate group.
EFFECT: invention extends the range of agents for inhibiting complement factor B (CFB) expression.
42 cl, 232 tbl, 135 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MODULATORS OF COMPLEMENT FACTOR B | 2014 |
|
RU2662967C2 |
| COMPOSITIONS AND METHODS FOR MODULATING HBV AND TTR EXPRESSION | 2014 |
|
RU2670614C9 |
| COMPOSITIONS AND METHODS FOR MODULATING PKK EXPRESSION | 2015 |
|
RU2703411C2 |
| COMPOSITIONS AND METHODS FOR MODULATION OF HBV AND TTR EXPRESSION | 2014 |
|
RU2782034C2 |
| COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF APOLIPOPROTEIN (A) | 2014 |
|
RU2824214C1 |
| COMPOSITIONS AND METHODS | 2014 |
|
RU2686080C2 |
| COMPOSITIONS AND METHODS OF MODULATING APOLIPOPROTEIN C-III EXPRESSION | 2014 |
|
RU2650510C2 |
| COMPOSITIONS AND METHODS FOR MODULATING EXPRESSION OF APOLIPOPROTEIN (A) | 2014 |
|
RU2699985C2 |
| CONJUGATED ANTISENSE COMPOUNDS AND USE THEREOF | 2014 |
|
RU2697152C2 |
| COMPOSITIONS AND METHODS FOR MODULATING THE EXPRESSION OF ANGIOPOIETIN-LIKE PROTEIN 3 | 2015 |
|
RU2734658C2 |
